Suppr超能文献

儿童肾移植后的最终身高及其预测因素。

Final height and its predictive factors after renal transplantation in childhood.

作者信息

Hokken-Koelega A C, van Zaal M A, van Bergen W, de Ridder M A, Stijnen T, Wolff E D, de Jong R C, Donckerwolcke R A, de Muinck Keizer-Schrama S M, Drop S L

机构信息

Department of Pediatrics, Sophia Children's Hospital/Erasmus University, Rotterdam.

出版信息

Pediatr Res. 1994 Sep;36(3):323-8. doi: 10.1203/00006450-199409000-00009.

Abstract

A retrospective study is reported assessing final height (FH) and its predictive factors in 52 patients (31 male, 21 female) who underwent renal transplantation (RTx) before the age of 15 y. They received prednisone daily or on alternate days as well as azathioprine. The study period covered 20 y. FH remained below the third height percentile [height standard deviation score for chronologic age (hSDSCA) < -1.88] for most of these patients (77% males, 71% females). Median (range) FH was 165.0 (143.0-176.8) cm in males and 153.0 (135.0-168.4) cm in females. Median difference between FH and target height was 15.0 and 15.4 cm for males and females, respectively. For both sexes, the median hSDSCA was already below -1.88 at the start of the first hemodialysis, after which it decreased significantly until the first RTx. After RTx, there was no significant improvement of hSDSCA. The predictive factors for FH were determined by evaluating various factors simultaneous in a multiple regression analysis. This analysis provided a regression equation for predicting FH. A higher hSDSCA at the time of the first RTx and alternate-day versus daily prednisone therapy both had a significantly positive influence on FH, whereas a longer duration of reduced GFR (< 50 mL/min/1.73 m2) had a significantly negative effect on FH. Other factors such as age or bone age at first RTx, primary renal disease, duration of initial dialysis, repeat RTx, and the cumulative dose of prednisone did not influence FH significantly. In conclusion, 71-77% of patients that received their first renal transplant before the age of 15 ended up with severely short adult stature. Optimization of the hSDSCA at first RTx appears very important. Long-term administration of prednisone on alternate days would then result in optimal FH, particularly if the GFR remains above 50 mL/min/1.73 m2.

摘要

一项回顾性研究报告了对52例15岁前接受肾移植(RTx)患者(31例男性,21例女性)的最终身高(FH)及其预测因素进行的评估。他们每日或隔日接受泼尼松以及硫唑嘌呤治疗。研究期长达20年。这些患者中的大多数(77%的男性,71%的女性)最终身高仍低于身高第三百分位数[按实际年龄计算的身高标准差评分(hSDSCA)<-1.88]。男性的中位(范围)最终身高为165.0(143.0 - 176.8)cm,女性为153.0(135.0 - 168.4)cm。男性和女性的最终身高与靶身高的中位差值分别为15.0 cm和15.4 cm。对于两性而言,首次血液透析开始时hSDSCA的中位数就已低于-1.88,此后直至首次肾移植时显著下降。肾移植后,hSDSCA无显著改善。通过在多元回归分析中同时评估各种因素来确定最终身高的预测因素。该分析提供了一个预测最终身高的回归方程。首次肾移植时较高的hSDSCA以及隔日与每日泼尼松治疗对最终身高均有显著的正向影响,而肾小球滤过率降低(<50 mL/min/1.73 m2)的持续时间较长对最终身高有显著的负向影响。其他因素,如首次肾移植时的年龄或骨龄、原发性肾病、初始透析时间、再次肾移植以及泼尼松的累积剂量对最终身高无显著影响。总之,71% - 77%在15岁前接受首次肾移植的患者最终成年身高严重矮小。首次肾移植时优化hSDSCA显得非常重要。隔日长期服用泼尼松将产生最佳的最终身高,特别是如果肾小球滤过率保持在50 mL/min/1.73 m2以上。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验